OTTAWA, ON – BIOTECanada, the national industry association representing Canada’s biotechnology ecosystem, is pleased to announce the appointment of Ian Mortimer, President and CEO of Xenon Pharmaceuticals, to its Board… Read More
Biotech leader brings deep experience scaling life science companies and will support Aspect’s growth and therapeutic pipeline advancement VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering the development of… Read More
VANCOUVER, BC – Vancouver Coastal Health has launched British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers. Located at Vancouver General Hospital (VGH), the new… Read More
MONTREAL, QC – The Pharmaceutical Sciences Group (PSG) and the Canadian Alliance for Skills and Training in Life Sciences (CASTL), announced a partnership to jointly offer training programs for Canada’s life‑sciences… Read More
Key oral presentations highlight new data from AbbVie’s novel investigational antibody-drug conjugates (ADCs) including telisotuzumab adizutecan (ABBV-400, Temab-A) in advanced non-small cell lung cancer (NSCLC), ABBV-706 in high-grade neuroendocrine neoplasms… Read More
